.jpeg)
Featured
boursenews.ma•Nov 12, 2026
Laprophan Unveils $37M State-of-the-Art Injectable Manufacturing Facility Ahead of IPO
Read More
Stay ahead of the market with our curated AI-powered financial news and expert analysis.
Morocco's T2S Group is advancing its expansion strategy with a 60 million dirham investment in a second radiopharmaceutical production facility through its subsidiary Cyclopharma. The Fez-based plant, which broke ground in October 2026, represents a strategic move to enhance nuclear medicine capabil...